The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

Fion Phua, founder of the Keeping Hope Alive volunteer platform, has been offering support to vulnerable households for ...

At the 2nd China International Supply Chain Expo CISCE being held here from Tuesday to Saturday a big FARMER BOB statue made a debut at McDonald bo ...

In ‘Culture Club’, Melanie Oliveiro speaks with Melanie Robert and Camille Razat (Camille in Netflix’s ‘Emily in Paris’), who ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities ...

Prime Minister Pham Minh Chinh on November 28 received visiting Minister-President of Germany’s State of Hessen Boris Rhein, ...

The global small-molecule injectable market is poised for significant growth, with an estimated valuation of USD 65.10 ...

The collaboration includes a phase 1 clinical study to start in the second quarter of 2025. The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) ...

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move that will boost the British drugmaker’s sales in the country in the midst ...